Meet Actress Anitaka Knight, a fierce advocate for health awareness and unique self-expression in the Black community.

Integra LifeSciences cuts 65 jobs at Princeton facility following device recall, joining wave of medtech layoffs affecting thousands in 2025-26.

Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now available in the Middle East – including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates (UAE).

Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the ...

DexCom Inc. (NASDAQ:DXCM) is one of the best medical technology stocks to invest in. On February 12, DexCom Inc.

Dexcom reports 13% Q4 revenue growth to $1.26B, beating analyst expectations despite mixed analyst ratings and competitive pressures.

The S&P 500 closed barely higher Feb. 13, with technology and communications services down on nagging fears of AI-disruption but equities drew support from optimism that cooling ...

U.S. stocks saw modest gains on Friday following positive inflation data, which supported speculations of potential Federal Reserve rate cuts. Meanwhile, technology shares regained some stability ...

Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit. The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months ...

New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

Dexcom's 2026 revenue estimates lagged analysts' expectations, according to data compiled by the London Stock Exchange Group ...

DexCom (NASDAQ: DXCM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, ...